Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May;44(9-10):775-783.
doi: 10.1002/elps.202200169. Epub 2023 Mar 17.

Next-generation liquid biopsy instruments: Challenges and opportunities

Shu Zhu  1 , Yaohui Fang  1 , Kefan Guo  1 , Zhonghua Ni  1 , Nan Xiang  1
Affiliations
Review

Next-generation liquid biopsy instruments: Challenges and opportunities

Shu Zhu et al. Electrophoresis. 2023 May.

Abstract

Conventional cancer diagnosis needs to excise diseased tissue from the patient's body for biopsy, causing severe injury to patients. Liquid biopsy (LB), with the superior advantage of minimal invasiveness, has shown its ability to cancer diagnosis in real-time and has been developing promising diagnostic instruments. However, until today, the developed instrument still cannot be an alternative to tissue biopsy in the majority of research and clinical settings. In this paper, we first summarize the challenges and limitations suffered by the existing LB instrument. Then, the opportunities and future progression of the next-generation instrument are discussed in detail. In all, we hope that the future LB instrument can be eventually integrated into the clinical workflow and serve as a validated and reliable tool for cancer diagnosis.

Keywords: cancer diagnosis; liquid biopsy; minimal invasiveness; next-generation.

PubMed Disclaimer

References

REFERENCES

    1. Corcoran RB. Liquid biopsy versus tumor biopsy for clinical-trial recruitment. Nat Med. 2020;26:1815-6.
    1. Battat S, Weitz DA, Whitesides GM. An outlook on microfluidics: the promise and the challenge. Lab Chip. 2022;22:530-6.
    1. Gronholm M, Feodoroff M, Antignani G, Martins B, Hamdan F, Cerullo V. Patient-derived organoids for precision cancer immunotherapy. Cancer Res. 2021;81:3149-55.
    1. Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic-implementation issues and future challenges. Nat Rev Clin Oncol. 2021;18:297-312.
    1. Taftaf R, Liu X, Singh S, Jia YZ, Dashzeveg NK, Hoffmann AD, et al. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer. Nat Commun. 2021;12:4867.

Publication types

LinkOut - more resources